Avalo Therapeutics AVTX Current ratio

Current ratio at other companies

Eli LillyLLY

1.4×+0.1×

AbbVieABBV

0.8×0.0×

Aclaris TherapeuticsACRS

3.5×-0.4×

Shattuck Labs, Inc.STTK

22.1×+13.0×

AnaptysBio, Inc.ANAB

7.6×-0.7×

AbCellera Biologics Inc.ABCL

12.8×+1.7×

FAQ

What is Avalo Therapeutics's current ratio?

Avalo Therapeutics (AVTX) reported current ratio of 19.3× in Q2 2026.

How has Avalo Therapeutics's current ratio changed year-over-year?

Avalo Therapeutics's current ratio increased by 55.2% year-over-year, from 12.4× to 19.3×.

What is the long-term trend for Avalo Therapeutics's current ratio?

Over 5 years (2020 to 2025), Avalo Therapeutics's current ratio has grown at a 36.6% compound annual growth rate (CAGR), from 1.7× to 8.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.